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da retina, nomeadamente CGRcom seus axónios e camada 
plexiforme interna.3 Os valores que encontramos poderão 
sugerir precisamente dano mais precoce a estas estruturas 
da retina, uma vez que na região nasal à fóvea se encontra 
o feixe papilomacular, onde existem em maior número de 
CGR e seus prolongamentos axonais. Apesar de o ERGmf 
ser um exame complementar de diagnóstico que pode detec-
tar alterações precoces na retinopatia dos antimaláricos13, 
o seu uso encontra-se limitado pelo custo, disponibilidade 
e necessidade de um centro especializado, em comparação 
com o SD-OCT, que é uma ferramenta atualmente mais dis-
ponível, dando informações da ultra-estrutura retiniana forma 
rápida e fácil. Noutros trabalhos, também foi demonstrada 
a capacidade de o SD-OCT demonstrar casos de toxicidade 
retiniana inicial, pela medição da espessura retiniana.2,5,10 Os 
nossos resultados sugerem que o SD-OCT pode detectar o 
adelgaçamento retiniano em casos de retinopatia precoce 
da HCQ. Trata-se de um estudo de pequena dimensão, pelo 
que mais estudos são necessários para conclusões mais defi-
nitivas. Novas modalidades de diagnóstico, nomeadamente 
estudos de segmentação retiniana também serão úteis para 
um maior entendimento da fisiopatologia da retinopatia dos 
antimaláricos.
Em conclusão, dado o potencial de perda visual progres-
siva e insidiosa associada à retinopatia dos antimaláricos, é 
fundamental que Oftalmologista tenha ferramentas capazes 
de detectar precocemente o dano à retina. O SD-OCT, exame 
amplamente disponível e fiável, pode ser uma ferramenta útil 
na avaliação do dano retiniano precoce dos antimaláricos.
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RESUMO
A prestação de cuidados especializados aos doentes diabéticos, nos países desenvolvidos, tem 
contribuído para o reduzido número de complicações a nível ocular na idade pediátrica. A efi-
ciência dos exames anuais oftalmológicos nesta faixa etária é atualmente assunto de debate. 
Os autores pretendem analisar as alterações a nível ocular nesta população e adequar os resul-
tados à dinâmica de um centro terciário, através do estudo retrospetivo dos processos clínicos 
dos doentes com diabetes tipo 1 inscritos e seguidos na consulta de Endocrinologia Pediátrica 
do Centro Hospitalar Lisboa Central entre Janeiro de 2008 e Julho de 2015. Foram avaliadas as 
características demográficas, a patologia de base e ocular e a referenciação e seguimento destes 
doentes na consulta de Oftalmologia Pediátrica.
Após análise dos processos clínicos de 304 doentes com diabetes tipo 1, foram incluídos no es-
tudo 110 doentes com referência a consulta de Oftalmologia no sistema informático. Apresenta-
vam idade média de 13,2 ±3.24 anos (4-20 anos), 57 eram do sexo masculino e 53 do sexo femi-
nino. A diabetes tipo 1 foi diagnosticada em média aos 7,5 ±3.0 anos (0,75-13 anos), com tempo 
de evolução médio de 6 ±3.3 anos (1-14 anos). A média do último valor de hemoglobina A1c era 
8,6% ±1.5 (4,9-14,4%). A primeira referenciação à consulta de Oftalmologia foi em média aos 
9,4 ±3.1 anos (2-19 anos), sendo que em 55 casos os doentes tinham menos de 10 anos e, desses, 
29 foram referenciados no primeiro ano após o diagnóstico (duração média da diabetes 2,0 ±0.7 
anos; 0-7 anos). Relativamente aos 55 doentes referenciados com idade igual ou superior a 10 
anos, 27 foram referenciados no primeiro ano após o diagnóstico (duração média da diabetes 
2,3 ±0.8 anos; 0-9 anos). Quanto à frequência do rastreio, 54 doentes foram reavaliados após 1 
ano, 15 após 2 anos, 1 após 3 anos e 1 após 5 anos. Não foi detetado nenhum caso de retinopatia 
diabética. 28 doentes apresentavam astigmatismo, 12 hipermetropia, 16 miopia, 5 estrabismo, 2 
blefaroptose e 1 catarata polar.
A Sociedade Internacional para a Diabetes Pediátrica e Adolescente recomenda o rastreio of-
talmológico 2 anos após o diagnóstico de diabetes tipo 1, em doentes acima dos 10 anos, e 5 
anos, se em idades inferiores. As diretrizes de 2014 da Academia Americana de Oftalmologia 
recomendam que o primeiro exame oftalmológico seja realizado 5 anos após o início da doença e 
repetido anualmente. Um estudo prévio efetuado no Hospital Dona Estefânia, entre 1999 e 2000, 
por Rodrigues P et al constatou uma baixa incidência de lesões oculares (6.4%) na população 
estudada, em acordo com os nossos resultados. Estudos mais recentes publicados na literatura 
são também concordantes e demonstram que a rara incidência de complicações da diabetes até à 
puberdade poderá justificar novas orientações nos próximos anos.
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The effectiveness of existing guidelines for ocu-
lar screening in this group is unclear because of ocular 
pathology low prevalence in younger ages and the paucity 
of studies regarding this subject. The authors intend to 
review the prevalence of ocular disease in a group of chil-
dren with type 1 diabetes, including DR, cataract, refrac-
tive error and strabismus.
MATERIAL AND METHODS
The authors performed a retrospective study of type 
1 diabetes’ patients registered and monitored in Pediatric 
Endocrinology Department of Centro Hospitalar de Lis-
boa Central since January of 2008 to July of 2015. Current 
study was based on electronic medical records consul-
tation. Patients that were referred to the Ophthalmology 
Department for observation were included. Study proto-
col was approved by Centro Hospitalar de Lisboa Central 
Administrative Council. 
Collected data included age, gender, race, child’s age 
at diagnosis of diabetes, diabetes duration, mean hemo-
globin A1c (HbA1c) in the past three years, most recent 
HbA1c, comorbidities, age at first eye examination and last 
one, number of eye exams and their frequency, presence 
and description of retinopathy, refractive error, strabis-
mus, blepharoptosis and cataract. Retinopathy screening 
was performed with dilated fundoscopic examinations 
by pediatric ophthalmologists. Refractive errors were 
obtained by cycloplegic refractions and classified by the 
amount of spherical equivalence (in diopters [D]). High 
myopia was considered if ≥4.0 D of myopia, high hype-
ropia if ≥3.0 D of hyperopia and high astigmatism was 
defined as ≥1.5 D cylindrical refractive error. High refrac-
tive error was defined as the presence of 1 or more of high 
myopia, high hyperopia and high astigmatism. Descriptive 
statistics (mean, minimum and maximum) were calculated 
for baseline characteristics of the subjects.
 A literature analysis was performed based on a 
PubMed search for the keywords: type 1 diabetes, ocular 
disease, pediatric age, screening and retinopathy.
RESULTS
A total of 304 medical records of patients with type 1 
diabetes were analyzed. 110 patients had been referred to 
Ophthalmology Department being included in the study. 
Baseline characteristics of these subjects are shown in 
Table 1. The mean age was 13.2 ±3.24 years (4-20 years), 
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57 were male and 53 female. Race was not specified in the 
majority of cases. Type 1 diabetes was diagnosed at 7.5 
±3.0 years on average (0.75-13 years) and mean disease 
duration was 6.0 ±3.3 years (1-14 years). The average 
of HbA1c in the three years was 9.2% ±1.8 (4.7-14.9%). 
The average of the last HbA1c value was 8.6% ±1.5 
(4.9-14.4%). 
Data regarding eye examination is described in Table 2. 
The first eye examination was performed at 9.4 ±3.1 years 
on average (2-19 years), in 55 cases the patients had less 
than 10 years and, of those, 29 were referred in the first year 
after diagnosis (mean duration diabetes of 2.0 ±0.7 years; 
0-7 years). Regarding the 55 patients older than 9 years, 27 
were referred in the first year after diagnosis (mean dura-
tion of diabetes 2.3 ± 0.8 years, 0-9 years). In 54 patients 
ophthalmological exam was repeated after 1 year, 15 after 
2 years, 1 after 3 years and 1 after 5 years. The remainder 
were not specified.
INTRODUCTION
Type 1 diabetes is the most common metabolic disease 
in children.1 In Portugal, 0,16% of people aged between 0 
and 19 years-old are affected by type 1 diabetes. During 
2013, 18,2 new cases were diagnosed per 100000 children 
aged 0 to 14 years-old.2
Duration of disease and metabolic control are the most 
important risk factors for the development of ocular com-
plications. Genetic load has shown to constitute an impor-
tant influence in this chapter.3
Although specialized care have also been contributing 
to the reduced number of ocular complications in pediatric 
age in developed countries, diabetic retinopathy (DR) is 
still the leading cause of blindness worldwide.4 To the 
extent of current knowledge, these findings are rare until 
puberty age.3,5 Nevertheless, the age at diagnosis and pre-
valence of DR in pediatric age are not well established and 
there is little of information about the onset and preva-
lence of other ocular complications because the majority 
of studies have focused on DR. 
In order to prevent and treat the ocular manifestations 
of this disease, a correct monitorization should include 
adequate metabolic control achievement, search for rela-
ted risk factors, effective screening implementation pro-
grams and treatment modalities optimization.
ABSTRACT
Specialized care provided to diabetic patients, in developed countries, has contributed to the re-
duced number of ocular complications in pediatric age. The effectiveness of annual eye examina-
tions in this group is unclear. 
The authors intend to determine the prevalence and onset of ocular disease in this population and 
adapt the results to the dynamics of a tertiary center, based on a retrospective study of type 1 dia-
betes patients’ medical records registered and monitored in Pediatric Endocrinology Department 
of Centro Hospitalar de Lisboa Central, between January of 2008 and July of 2015. Demographic 
characteristics, underlying and ocular disease, referral and follow-up of these patients in the Pe-
diatric Ophthalmology Department were evaluated. 
Medical records of 304 patients with type 1 diabetes were analyzed. 110 patients referred to 
Ophthalmology Department had been included in the study. The mean age was 13.2 ±3.24 years 
(4-20 years), 57 were male and 53 female. Type 1 diabetes was diagnosed at 7.5 ±3.0 years on 
average (0.75-13 years) and mean disease duration was 6.0 ±3.3 years (1-14 years). The average 
of the last hemoglobin A1c value was 8.6% ±1.5 (4.9-14.4%). The first eye exam was performed 
at 9.4 ±3.1 years on average (2-19 years), in 55 cases the patients had less than 10 years and, of 
those, 29 were referred in the first year after diagnosis (mean duration diabetes of 2.0 ±0.7 years; 
0-7 years). Regarding the 55 patients older than 9 years, 27 were referred in the first year after 
diagnosis (mean duration of diabetes 2.3 ±0.8 years, 0-9 years). In 54 patients ophthalmological 
exam was repeated after 1 year, 15 after 2 years, 1 after 3 years and 1 after 5 years. No diabetic 
retinopathy cases were found. 28 astigmatism, 12 hyperopia, 16 myopia, 5 strabismus, 2 blepha-
roptosis and 1 polar cataract were diagnosed.
International Society for Pediatric and Adolescent Diabetes recommend ophthalmological initial 
screening 2 years after the diagnosis of type 1 diabetes, in patients above 10 years, and 5 years af-
ter, if lower ages. American Academy of Ophthalmology 2014 guidelines recommend that the first 
eye examination should begin 5 years after the diagnosis and repeated annually. A previous study 
conducted at Hospital Dona Estefânia, between 1999 and 2000, by Rodrigues P et al has described 
a low incidence of ocular lesions (6.4%) in the studied population, being in agreement with our re-
sults. Recent published studies are also consistent and demonstrate that the rare incidence of ocular 
complications of diabetes until puberty can justify new guidelines in the coming years.
Key-words
Diabetes Tipo 1, Patologia Ocular, Idade Pediátrica, Rastreio, Retinopatia
Ana Basílio, Rita Proença, Sara Crisóstomo, Ana Paixão, Cristina Ferreira, Ana Xavier, Cristina Brito, Alcina Toscano
Tabela 1 |
Age
   Mean
   Minimum (min.)
   Maximum (max.)
   Standard Deviation (SD)
13.2
4
20
3.24
Gender - n (%)
   Male
   Female
57 (51.8%)
53 (48.2%)
Age at diabetes diagnosis (years [yrs])
   Mean
   Min.
   Max.
   SD
7.5
0.75
13
3.0
Diabetes duration (yrs)
   Mean
   Min.
   Max.
   SD
6.0
1
14
3.3
HbA1c in the last 3 years (%)
   Mean
   Min.
   Max.
   SD
9.2
4.7
14.9
1.8
Last HbA1c (%)
   Mean
   Min.
   Max.
   SD
8.6
4.9
14.4
1.5
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pediatric population.10,11,12
A previous study conducted at Hospital Dona Estefâ-
nia, between 1999 and 2000, by Rodrigues P et al descri-
bed a low incidence of ocular lesions (6.4%) in studied 
population, being in agreement with our results. They des-
cribed 1 case of a 17-year-old girl with non-proliferative 
DR (1.6%), 11 years after the diagnosis of diabetes, and 3 
cases of bilateral cataract (4.8%).13
International Society for Pediatric and Adolescent Dia-
betes recommend initial screening 2 years after the diag-
nosis of type 1 diabetes, in patients above 10 years, and 5 
years after, if lower ages.14 American Academy of Pedia-
trics guidelines suggest initiating annual examinations 3 to 
5 years after diabetes diagnosis or after the age of 9 years, 
whichever occurs later.1 American Academy of Ophthal-
mology 2014 guidelines recommend that the first eye exa-
mination should be performed 5 years after the diagnosis 
and repeated annually.4 The heterogeneity of current guide-
lines related to the age of first ophthalmological examina-
tion in diabetic children demonstrate that the prevalence of 
ocular complications must be noticed, in order to allow the 
improvement and concordance of recommended strategies.
Results obtained in our retrospective review are in agree-
ment with published studies. The development of diabetic 
retinopathy until puberty is rare. The occurrence of refrac-
tive errors and strabismus are similar to healthy children. 
In conclusion, the rare incidence of ocular complica-
tions of diabetes until puberty can justify new guidelines 
in the coming years. An effort to enhance the screening of 
ocular disease according to the age and the most frequent 
related diseases should be performed.
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Ocular findings are described in Table 3. No children 
were found to have diabetic retinopathy during the period 
of the study. 1 case of congenital unilateral posterior polar 
cataract was found (0.9%), with normal visual acuity. 1 
patient (0.9%) with Kearns-Sayre syndrome was found to 
have exotropia. 28 patients (25.5%) were found to have 
astigmatism, including 6 cases of high astigmatism (5.5%). 
16 children (14.5%) had myopia, including 3 cases of high 
myopia (2.7%). 12 cases (10.9%) of hyperopia were regis-
tered, 1 of high hyperopia (0.9%). High refractive error 
was found in 10 patients (9.1%).
DISCUSSION
A group of 110 type 1 diabetic patients (4-20 years; 
mean 13.2 ±3.24) was studied, providing important data 
about their referral to ocular screening and the prevalence 
of ocular findings in a tertiary center. The first eye exam 
was performed at 9.4 ±3.1 years on average (2-19 years) 
and in 50% of the initial exams children were less than 10 
years-old. The majority of these earlier exams might be 
explained by ocular complaints or in the context of pres-
chooler screening. Annual screening was the most com-
monly observed regimen. One limitation of our study was 
the chosen technique for screening. In all cases, dilated 
fundoscopic examinations were performed by pediatric 
ophthalmologists. The use of fundus photography has been 
found to be more sensitive than fundoscopy for detecting 
mild retinopathy, particularly in children, who are more 
difficult to examine than adults.6
In our study, we didn’t find any case of DR. Geloneck 
M et al7 in 2015, have reviewed the literature to identify 12 
studies reporting the occurrence of DR during childhood 
(published between 1981 until 2012) and verified that repor-
ted prevalence of DR among children was 9% to 28%. Pro-
bable explanations for this wide range of prevalence are the 
differing baseline characteristics (ages at examination and 
metabolic control), different screening modalities and the 
improvements in the provided care to these patients over 
time. They have also found that the shortest duration of dia-
betes before the development of proliferative DR was 5 to 
6 years and the earliest documented age of severe DR was 
15 years-old.7
Regarding the incidence of cataract, in our study we 
found 1 case of posterior polar cataract (0.9%), with no 
commitment of visual function. Reported incidence of 
diabetic cataract is 0.7% to 3.4%.8,9 Posterior subcapsular, 
lamellar, flakelike and dense milky-white cataracts are the 
described morphologies.8,9 To the best of our knowledge, 
none association was reported between posterior polar 
cataract and diabetes.
The prevalence of high refractive errors and strabis-
mus in our study was found to be similar to a nondiabetic 
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Tabela 2 |
Age at first eye examination (yrs)
   Mean
   Min.
   Max.
   SD
9.4
2
19
3.1
   < 10 years-old
              In the 1st year of diagnosis
              Diabetes duration (yrs)
   Mean
   Min.
   Max.
   SD
55
29
2.0
0
7
0.7
   ≥ 10 years-old
               In the 1st year of diagnosis
               Diabetes duration (yrs)
     Mean
     Min.
     Max.
     SD
55
27
2.3
0
9
0.8
Re-evaluation
   1 year
   2 years
   3 years
   5 years
54
15
1
1
Tabela 3 |
Diabetic retinopathy - n (%) 0 (0%)
Cataract - n (%) 1 (0.9%)
Strabismus - n (%)
   Phoria
   Tropia
5 (4.5%)
4 (3.6%)
1 (0.9%)
Blepharoptosis - n (%) 2 (1.8%)
Refractive error - n (%)
   Myopia
        Mean age of diagnosis (yrs)
   Hyperopia
        Mean age of diagnosis (yrs)
   Astigmatism
        Mean age of diagnosis (yrs)
   High refractive error
        Mean age of diagnosis (yrs)
56 (50.9%)
16 (14.5%)
8.6 ±0.8  
12 (10.9%)
6.1 ±0.4  
28 (25.5%)
7.2 ±1.1
10 (9.1%)
9.1 ±1.3  
